US 8323635
Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
granted A61KA61K31/255A61K31/475
Quick answer
US patent 8323635 (Methods of using interleukin-1 receptor antagonist as a myeloprotective agent) held by GENERAL REGENERATIVES, LTD. expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GENERAL REGENERATIVES, LTD.
- Grant date
- Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/255, A61K31/475, A61K31/513, A61K31/519